DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,190,140 | +105036.0% | 4,797 | +1.7% | 0.05% | +10.6% |
| Q2 2023 | $1,132 | -1.7% | 4,716 | +3.3% | 0.05% | -7.8% |
| Q1 2023 | $1,151 | +1.6% | 4,565 | +6.9% | 0.05% | 0.0% |
| Q4 2022 | $1,133 | -99.9% | 4,269 | 0.0% | 0.05% | -5.6% |
| Q3 2022 | $1,103,000 | +1.9% | 4,269 | 0.0% | 0.05% | +8.0% |
| Q2 2022 | $1,082,000 | -11.7% | 4,269 | +2.3% | 0.05% | +4.2% |
| Q1 2022 | $1,225,000 | -10.8% | 4,174 | 0.0% | 0.05% | -2.0% |
| Q4 2021 | $1,374,000 | -18.9% | 4,174 | -25.0% | 0.05% | -24.6% |
| Q3 2021 | $1,695,000 | +51.7% | 5,567 | +33.8% | 0.06% | +51.2% |
| Q2 2021 | $1,117,000 | +19.0% | 4,162 | -0.2% | 0.04% | +13.2% |
| Q1 2021 | $939,000 | -8.2% | 4,171 | -9.4% | 0.04% | -11.6% |
| Q4 2020 | $1,023,000 | +3.1% | 4,606 | 0.0% | 0.04% | -6.5% |
| Q3 2020 | $992,000 | +21.6% | 4,606 | -0.2% | 0.05% | +15.0% |
| Q2 2020 | $816,000 | +18.8% | 4,614 | -7.1% | 0.04% | 0.0% |
| Q1 2020 | $687,000 | -9.7% | 4,964 | +0.0% | 0.04% | +2.6% |
| Q4 2019 | $761,000 | +3.5% | 4,962 | -2.4% | 0.04% | -2.5% |
| Q3 2019 | $735,000 | +9.4% | 5,083 | +8.1% | 0.04% | +11.1% |
| Q2 2019 | $672,000 | +3.2% | 4,704 | -4.5% | 0.04% | +2.9% |
| Q1 2019 | $651,000 | +16.9% | 4,928 | -8.8% | 0.04% | +2.9% |
| Q4 2018 | $557,000 | -5.1% | 5,403 | +0.1% | 0.03% | +9.7% |
| Q3 2018 | $587,000 | +11.2% | 5,400 | +0.9% | 0.03% | +6.9% |
| Q2 2018 | $528,000 | +0.8% | 5,350 | 0.0% | 0.03% | -3.3% |
| Q1 2018 | $524,000 | +4.0% | 5,350 | -1.4% | 0.03% | +7.1% |
| Q4 2017 | $504,000 | +13.0% | 5,425 | +4.3% | 0.03% | +7.7% |
| Q3 2017 | $446,000 | -30.4% | 5,200 | -31.5% | 0.03% | -31.6% |
| Q2 2017 | $641,000 | -12.8% | 7,590 | -11.6% | 0.04% | -13.6% |
| Q1 2017 | $735,000 | +9.9% | 8,590 | 0.0% | 0.04% | +4.8% |
| Q4 2016 | $669,000 | -0.6% | 8,590 | 0.0% | 0.04% | 0.0% |
| Q3 2016 | $673,000 | -22.5% | 8,590 | 0.0% | 0.04% | -23.6% |
| Q2 2016 | $868,000 | +2.4% | 8,590 | -3.9% | 0.06% | +1.9% |
| Q1 2016 | $848,000 | +2.0% | 8,936 | -0.2% | 0.05% | +3.8% |
| Q4 2015 | $831,000 | +8.9% | 8,951 | -0.1% | 0.05% | +6.1% |
| Q3 2015 | $763,000 | -0.5% | 8,956 | 0.0% | 0.05% | +8.9% |
| Q2 2015 | $767,000 | -2.4% | 8,956 | -3.2% | 0.04% | 0.0% |
| Q1 2015 | $786,000 | -9.8% | 9,253 | -9.0% | 0.04% | -8.2% |
| Q4 2014 | $871,000 | +0.9% | 10,168 | -10.5% | 0.05% | 0.0% |
| Q3 2014 | $863,000 | -3.6% | 11,361 | 0.0% | 0.05% | 0.0% |
| Q2 2014 | $895,000 | -3.5% | 11,361 | -8.1% | 0.05% | -5.8% |
| Q1 2014 | $927,000 | +12.6% | 12,361 | +15.9% | 0.05% | +13.0% |
| Q4 2013 | $823,000 | +22.1% | 10,663 | +9.6% | 0.05% | +9.5% |
| Q3 2013 | $674,000 | +9.4% | 9,733 | 0.0% | 0.04% | +5.0% |
| Q2 2013 | $616,000 | +2.7% | 9,733 | +0.9% | 0.04% | +2.6% |
| Q1 2013 | $600,000 | – | 9,643 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |